arrow
J

J.F. Silvestre

hospital universitario dr balmis
H指数:28
被引数:3,433

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy of abrocitinib and dupilumab in itch-dominant atopic dermatitis: An analysis of 2 trials

阿布罗西替布和度普利尤米在瘙痒主导性特应性皮炎中的疗效:两项试验的分析

2026-02-170
OAAI
Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND

特应性皮炎中度至重度患者接受特立珠单抗治疗长达6年的长期安全性与有效性:开放标签扩展试验ECZTEND的最终结果

2026-02-050
OAAI
Clinical Factors Associated With Current Relevance in Allergic Contact Dermatitis: Development of Predictive Models Based on Data From the Spanish Contact Dermatitis Register (REIDAC)

与过敏性接触性皮炎当前相关性相关的临床因素:基于西班牙接触性皮炎登记处(REIDAC)数据开发的预测模型

2026-02-010
OAAI
Characteristics, treatment, and safety profile of patients with atopic dermatitis according to eligibility for randomized clinical trials: an analysis from the Spanish Atopic Dermatitis Registry (BIOBADATOP)

特应性皮炎患者的特征、治疗及安全性概况:根据随机临床试验的入选资格进行分析——西班牙特应性皮炎登记系统(BIOBADATOP)的分析

2025-12-020
OAAI
Discordant Patch Test Reactions to 2-Bromo-2-Nitro-Propane-1,3-Diol (Bronopol): A Multicenter Study From REIDAC
2025-12-010
PRE
Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019-2024

肛门生殖器接触性皮炎在西班牙:REIDAC研究(2019-2024年进行斑贴试验的患者)

2025-12-010
OAAI
Efficacy of up to 4 years of tralokinumab in adults with moderate-to-severe atopic dermatitis

中重度特应性皮炎成人患者中曲尼司特长达4年的疗效

2025-11-011
OAAI
Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of eight clinical trials

特应性皮炎患者中特立洛金单抗的安全性(随访长达4.5年):一项八项临床试验的整合分析

2025-11-011
OAAI
[[Translated article]]Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) still be part of the Baseline Series?

[[翻译后的文章]]羟基异己基3-环己烯羧醛(Lyral®)是否仍应包含在基础系列中?

2025-10-090
OAAI
The Changing Spectrum of Pediatric Allergic Contact Dermatitis: A Prospective Multicentric Study in Spain

儿童过敏性接触性皮炎的演变谱:一项在西班牙进行的多中心前瞻性研究

2025-08-180
PRE
Clinical Characteristics, Diagnostic Approaches, Therapeutic Management, and Associated Comorbidities of Prurigo Nodularis (Chronic Nodular Prurigo): An Observational Study in Clinical Practice in Spain

结节性痒疹(慢性结节性痒疹)的临床特征、诊断方法、治疗管理及相关合并症:一项在西班牙临床实践中的观察性研究

2025-06-010
PRE
Allergic Contact Dermatitis to a Disinfectant Containing N-(3-Aminopropyl)-N-Dodecylpropane-1,3-Diamine in a Supermarket Deli Kitchen Worker: An Unrecognised Occupational Allergen?

对含N-(3-氨基丙基)-N-十二烷基丙烷-1,3-二胺的消毒剂引起的过敏性接触性皮炎:一名超市熟食厨房工人中的一例未识别的职业性过敏原?

2025-02-250
PRE
Clinical-Epidemiological Profile, and Treatment Response in Relation to Associated Atopic Comorbidity in Atopic Dermatitis. Experience From the BIOBADATOP Registry
2025-02-010
OAAI